You see a filtered list - Keywords: Kießling-Selection
[1]T. Opacic, S. Dencks, B. Theek, M. Piepenbrock, D. Ackermann, A. Rix, T. Lammers, E. Stickeler, S. Delorme, G. Schmitz, F. Kießling,
"Motion model ultrasound localization microscopy for preclinical and clinical multiparametric tumor characterization", Nature Communications, vol. 9, no. 1, 2018, pp. 1527.
[bibtex] [url] [doi]
[2]Y. Tsvetkova, N. Beztsinna, M. Baues, D. Klein, A. Rix, S. K. Golombek, W. Al Rawashdeh, F. Gremse, M. Barz, K. Koynov, S. Banala, W. Lederle, T. Lammers, F. Kießling,
"Balancing Passive and Active Targeting to Different Tumor Compartments Using Riboflavin-Functionalized Polymeric Nanocarriers", Nano letters, vol. 17, no. 8, 2017, pp. 4665–4674.
[bibtex] [url] [doi]
[3]T. Lammers, P. Koczera, S. Fokong, F. Gremse, J. Ehling, M. Vogt, A. Pich, G. Storm, M. van Zandvoort, F. Kießling,
"Theranostic USPIO-Loaded Microbubbles for Mediating and Monitoring Blood-Brain Barrier Permeation", Advanced functional materials, vol. 25, no. 1, 2015, pp. 36–43.
[bibtex] [url] [doi]
[4]A. Schober, M. Nazari Jahantigh, Y. Wei, K. Bidzhekov, F. Gremse, J. Grommes, R. T. A. Megens, K. Heyll, H. Noels, M. Hristov, S. Wang, F. Kießling, E. N. Olson, C. Weber,
"MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1", Nature medicine, vol. 20, no. 4, 2014, pp. 368–376.
[bibtex] [url] [doi]
[5]S. Kunjachan, R. Pola, F. Gremse, B. Theek, J. L. A. Ehling, D. Möckel, B. Hermanns-Sachweh, M. Pechar, K. Ulbrich, W. E. Hennink, G. Storm, W. Lederle, F. Kießling, T. Lammers,
"Passive versus Active Tumor Targeting Using RGD- and NGR-Modified Polymeric Nanomedicines", Nano letters, vol. 14, no. 2, 2014, pp. 972–981.
[bibtex] [url] [doi]
[6]F. Gremse, C. F. H. Grouls, M. Palmowski, T. Lammers, A. de Vries, H. Grüll, M. Das, G. Mühlenbruch, S. Akhtar, A. Schober, F. Kießling,
"Virtual elastic sphere processing enables reproducible quantification of vessel stenosis at CT and MR angiography", Radiology, vol. 260, no. 3, 2011, pp. 709–717.
[bibtex] [url] [doi]
[7]F. Kießling, J. Huppert, C. Zhang, J. Jayapaul, S. Zwick, E. C. Woenne, M. M. Mueller, H. Zentgraf, M. Eisenhut, Y. Addadi, M. Neeman, W. Semmler,
"RGD-labeled USPIO Inhibits Adhesion and Endocytotic Activity of αvβ3-Integrin–expressing Glioma Cells and Only Accumulates in the Vascular Tumor Compartment", Radiology, vol. 253, no. 2, 2009, pp. 462–469.
[bibtex] [url] [doi]
[8]M. Palmowski, J. Huppert, P. Hauff, M. Reinhardt, K. Schreiner, M. A. Socher, P. Hallscheidt, G. W. Kauffmann, W. Semmler, F. Kießling,
"Vessel fractions in tumor xenografts depicted by flow- or contrast-sensitive three-dimensional high-frequency Doppler ultrasound respond differently to antiangiogenic treatment", Cancer research, vol. 68, no. 17, 2008, pp. 7042–7049.
[bibtex] [url] [doi]
[9]J. Hamzah, M. Jugold, F. Kießling, P. Rigby, M. Manzur, H. H. Marti, T. Rabie, S. Kaden, H. Gröne, G. J. Hämmerling, B. Arnold, R. Ganss,
"Vascular normalization in Rgs5-deficient tumours promotes immune destruction", Nature, vol. 453, no. 7193, 2008, pp. 410–414.
[bibtex] [url] [doi]
[10]F. Kießling, S. Greschus, M. P. Lichy, M. Bock, C. Fink, S. Vosseler, J. Moll, M. M. Mueller, N. E. Fusenig, H. Traupe, W. Semmler,
"Volumetric computed tomography (VCT): a new technology for noninvasive, high-resolution monitoring of tumor angiogenesis", Nature Medicine, vol. 10, no. 10, 2004, pp. 1133–1138.
[bibtex] [url] [doi]